Review: taking Methylprednisolone and Mucinex dm together


Summary

Drug interactions are reported among people who take Methylprednisolone and Mucinex dm together. This review analyzes the effectiveness and drug interactions between Methylprednisolone and Mucinex dm. It is created by eHealthMe based on reports of 17 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Methylprednisolone and Mucinex dm >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Methylprednisolone

Methylprednisolone has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. (latest outcomes from Methylprednisolone 22,611 users)

Mucinex Dm

Mucinex dm has active ingredients of dextromethorphan hydrobromide; guaifenesin. It is often used in cough. (latest outcomes from Mucinex dm 814 users)

On Aug, 26, 2016

17 people who take Methylprednisolone, Mucinex Dm are studied.


Number of reports submitted per year:

Methylprednisolone and Mucinex dm drug interactions.

Drug effectiveness over time:

Methylprednisolone:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Mucinex Dm:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Methylprednisolone:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Mucinex Dm:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Methylprednisolone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Mucinex Dm:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • colitis
  • dyspnoea
  • failure to thrive
  • dizziness
  • heart rate decreased
  • heart rate irregular
1 - 6 months:
  • colitis
  • dyspnoea
  • failure to thrive
not specified:
  • back pain
  • confusional state
  • fall
  • fatigue
  • headache
  • hypotension
  • loss of consciousness
  • pain
  • pneumonia
  • asthenia

Most common drug interactions by gender *:

female:
  • asthenia
  • back pain
  • confusional state
  • dizziness
  • fall
  • fatigue
  • pain
  • pneumonia
  • abdominal distension
  • amaurosis fugax
male:
  • colitis
  • dyspnoea
  • failure to thrive
  • brain oedema
  • cardiac ventricular disorder
  • chorea
  • contusion
  • coronary artery disease
  • disseminated intravascular coagulation
  • dyskinesia

Most common drug interactions by age *:

30-39:
  • chorea
  • dyskinesia
  • emotional disorder
  • extrapyramidal disorder
  • family stress
  • headache
  • injury
  • psoriasis
  • tardive dyskinesia
  • tremor
40-49:
  • dizziness
50-59:
  • asthenia
  • back pain
  • fall
  • pneumonia
  • abdominal distension
  • amaurosis fugax
  • anxiety
  • arthralgia
  • ascites
  • atrophic vulvovaginitis
60+:
  • colitis
  • dyspnoea
  • failure to thrive
  • aphasia
  • asthenia
  • atrial fibrillation
  • brain oedema
  • cardiac ventricular disorder
  • carotid artery stenosis
  • cerebral atrophy

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Methylprednisolone and Mucinex dm?

Can you answer these questions?

More questions for: Methylprednisolone, Mucinex dm

You may be interested in these reviews

More reviews for: Methylprednisolone, Mucinex dm

On eHealthMe, Methylprednisolone (methylprednisolone) is often used to treat rheumatoid arthritis. Mucinex dm (dextromethorphan hydrobromide; guaifenesin) is often used to treat cough. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.